Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2026-07-21 16:32:05 ET · period of report 2026-07-18 · accession 0001938861-26-000021 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-21 16:32 | 2026-07-18 | ANIP | Cook Meredith | SVP, GC, SEC | F - Tax | $79.20 | -2,466 | 74.9K | -3% | -$195.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-18 | F | D | 2,466 | $79.20 | 74,924 | D | — | — | (F1) Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,820 shares of restricted stock, the grant of which was previously reported on July 20, 2022. |